Beating up intelligent design

Late last year, following the Kansas State Board of Education's decision to treat evolution as a disputed theory in elementary and middle school classrooms, Paul Mirecki, a professor of religious studies at the University of Kansas, announced plans to teach a counter-course: "Special Topics in Religion: Intelligent Design, Creationism, and other Religious Mythologies." Soon after that, the trouble started.After comments Mirecki made about the course on a privat

Written byIshani Ganguli
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Late last year, following the Kansas State Board of Education's decision to treat evolution as a disputed theory in elementary and middle school classrooms, Paul Mirecki, a professor of religious studies at the University of Kansas, announced plans to teach a counter-course: "Special Topics in Religion: Intelligent Design, Creationism, and other Religious Mythologies." Soon after that, the trouble started.

After comments Mirecki made about the course on a private listserv were made public in late November, the university reevaluated the class. "The fundies," Mirecki wrote of religious conservatives on Nov. 19, 2005, to a university group he advises, the Society of Open-Minded Atheists and Agnostics, "want it all taught in a science class, but this will be a nice slap in their big fat face by teaching it as a religious studies class under the category [of] mythology."

Mirecki apologized for the comments and withdrew the course on Dec. 1, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies